- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01399892
Effect of Fiber Supplementation in Children With Type 1 Diabetes
July 21, 2011 updated by: Mayo Clinic
Effects of Fiber Supplementation on Glycemic Excursions and Incidence of Hypoglycemia in Children With Type 1 Diabetes
High fiber foods are recommended as a preferential source of carbohydrate by the Nutrition Study Group of the European Association for the Study of Diabetes.
Dietary fibers may delay glucose absorption and reduce postprandial glycemic excursion.
They also appear to have a beneficial effect on cholesterol levels.
It has been shown, in few short term adult studies, that high fiber foods reduce postprandial blood glucose levels.
The American Diabetes Association feels that there is little evidence confirming the positive effect of high fiber foods on blood glucose control.
It is not clear whether a high fiber diet can improve glycemic control and/or reduce the risk of hypoglycemic events.
Our hypothesis is that children with type 1 diabetes will benefit from having added fibers in their diet.
The investigators plan to study blood glucose values using a continuous blood glucose monitor before and after dietary fibers are introduced.
This will help us determine whether a diet rich in fiber should be recommended in all children with type 1 diabetes mellitus
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 years to 16 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The inclusion criteria are: Diagnosis of type I diabetes for at least two years prior to enrollment, the ability tolerate wearing the continuous blood glucose monitoring device for a total of 6 days, and the ability to follow a prescribed meal plan.
Exclusion Criteria:
- The exclusion criteria are: Medical conditions that could potentially affect the absorption of nutrients such as celiac disease of inflammatory bowel disease and the use of any fiber supplements at home.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
incidence of hypoglycemia after fiber supplementation
Time Frame: continuous glucose monitoring over 72 hours
|
continuous glucose monitoring over 72 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Aida N Lteif, MD, Mayo Clinic
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2008
Primary Completion (Actual)
May 1, 2010
Study Completion (Actual)
December 1, 2010
Study Registration Dates
First Submitted
July 20, 2011
First Submitted That Met QC Criteria
July 21, 2011
First Posted (Estimate)
July 22, 2011
Study Record Updates
Last Update Posted (Estimate)
July 22, 2011
Last Update Submitted That Met QC Criteria
July 21, 2011
Last Verified
July 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 08-002142
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 1 Diabetes
-
Poznan University of Medical SciencesUnknownDiabetes Mellitus Type 1 | Remission of Type 1 Diabetes | Chronic Complications of DiabetesPoland
-
Eledon PharmaceuticalsWithdrawnBrittle Type 1 Diabetes MellitusUnited States
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)CompletedType 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes MellitusUnited States, Australia
-
Hoffmann-La RocheCompletedType 2 Diabetes, Type 1 DiabetesAustria, United Kingdom
-
Shanghai Changzheng HospitalRecruitingBrittle Type 1 Diabetes MellitusChina
-
Capillary Biomedical, Inc.TerminatedType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMAustria
-
Capillary Biomedical, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Insulin-Dependent, 1Australia
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
Rabin Medical CenterDreaMed DiabetesTerminated
Clinical Trials on soluble fiber in the form of benefiber
-
UPECLIN HC FM Botucatu UnespFundação de Amparo à Pesquisa do Estado de São PauloCompletedHIV Infections | Hypertriglyceridemia
-
Rennes University HospitalTerminated
-
Zagazig UniversityUnknownCesarean Section Complications
-
Nepal Health Research CouncilMicrobe Literacy Initiative; Partnership for Sustainable Development Nepal...Not yet recruiting
-
dr. Muhammad Abdelhafez Mahmoud, MDCompletedCovid19 | Telemedicine | Pandemic | Virtual ClinicSaudi Arabia
-
University Hospitals Cleveland Medical CenterCompleted
-
Unity Health TorontoUnknown
-
Florida International UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingOsteoporosisUnited States
-
I.M. Sechenov First Moscow State Medical UniversityActive, not recruitingProstatic HyperplasiaRussian Federation